Pharma procurement killed your last deal.
It will not kill this one.
IoT companies with proven technology lose months — sometimes years — to procurement culture, stakeholder misalignment, and regulatory complexity. Dametra removes that wall. We run the commercial and implementation process so your technology reaches deployment, not a drawer.
About Dametra
We have been on both sides of this table.
Our team has over 15 years of direct experience in pharmaceutical supply chains and medical IoT — including cold chain deployments at global scale and commercial engagements with major European manufacturers and CDMOs. We understand how pharma buys. We know which objections kill deals in week one, which stakeholders control the budget, and how to design a pilot that becomes a reference case, not a report.
-
Multiple years in the pharma research, manufacturing, supply chain and medical IoT
-
Cold chain deployments at multiMillions unit scale across global pharmaceutical manufacturers
-
Engagements spanning CDMOs, global pharma, and connected diagnostics — from pilot to multi-site commercial deployment
WE OFFER COMMERCIAL SOLUTIONS ACROSS ALL PHARMA OPERATIONS
02
The Market Is Ready
GDP compliance, real-time visibility, and operational efficiency are driving demand for IoT across pharmaceutical supply chains and manufacturing. The budgets exist. The use cases are proven.
03
We Bridge the Gap
Dametra connects innovative IoT companies with pharmaceutical manufacturers, CDMOs, and biotech organisations — and guides the path from first conversation to live deployment.
Heading 6
PROCESS
A European IoT company cut time-to-first-pharma-deployment from 18 months to under 90 days
Market Access
Commercial Representation
Pilot Deployment
Implementation Guidance
We represent your technology directly to pharmaceutical buyers — translating technical capability into the business case pharma decision-makers need to act.
We ensure new technologies integrate smoothly into validated pharmaceutical environments — addressing quality, compliance, and operational requirements from day one.
We open doors that take years to knock on alone. Our industry relationships put your technology in front of the right decision-makers at the right organisations.
The first deployment is the hardest. We design, coordinate, and support pilot projects that turn interest into signed agreements and operational proof points.
No pitch.
One conversation to map what makes sense for your situation.
What does another 18 months in procurement cost?
Every month a proven technology sits in an unanswered procurement review is revenue not recognised, a competitor relationship deepening, and a pilot window closing. The first European reference case is the hardest. The companies that build it in year one own the market by year three.
The barrier is not the technology. It is the calendar.
01
Evaluate
We assess your technology's maturity, regulatory fit, and the strongest entry points within the European pharmaceutical market.
02
Position
We develop a targeted market entry strategy — identifying the right use cases, stakeholders, and commercial framing for your specific product.
03
Represent
We introduce your technology to qualified pharmaceutical manufacturers, CDMOs, and healthcare operators through direct industry engagement.
04
Deploy
We secure and manage the first pilot project — delivering a live, measurable deployment with a real pharmaceutical partner.
05
Scale
We support expansion from initial pilot to multi-site commercial deployment across European markets.
Regulated Delivery
Vendor-Agnostic
GxP Mindset
Data Integrity by Design
Cross-Functional Governance
SPEED iN QUALITY